| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-14 | 2025-03-31 | 2024-03-12 | 2023-03-07 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | 40.36 | 56.59 | 46.74 | 38.03 | 31.32 | 23.56 | 21.03 |
| Cost of Revenue | 12.68 | 16.69 | 15.68 | 10.8 | 3.63 | 2.15 | 5.8 |
| Gross Profit | 27.68 | 39.9 | 31.06 | 27.24 | 27.68 | 21.41 | 15.23 |
| Operating Expenses | 291 | 123.3 | 136.5 | 77.87 | 63.52 | 56.67 | 153.9 |
| Research & Development | 14.72 | 9.64 | 12.75 | 9.05 | 9.2 | 9.96 | 85.52 |
| Selling, General and Administrative | 272.1 | 119 | 119.6 | 64.89 | 50.58 | 42.97 | 64.7 |
| Other Operating Expenses | 4.12 | -5.36 | 4.11 | 3.92 | 3.74 | 3.74 | 3.71 |
| Operating Income | -263.3 | -83.4 | -105.4 | -50.63 | -35.84 | -35.26 | -138.7 |
| Net Non-Operating Interest | -8.25 | -1.96 | -1.07 | -9.6 | -11.76 | -13.12 | -16.43 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0.46 |
| Interest Expense | 8.25 | 1.96 | 1.07 | 9.6 | 11.76 | 13.12 | 16.89 |
| Equity & Other Income/(Expense) | -62.85 | 12.55 | -7.82 | 36.88 | -40.82 | 0.802 | -23.47 |
| Income Before Tax | -334.4 | -72.81 | -114.3 | -23.36 | -88.42 | -47.57 | -178.6 |
| Income Tax Expense | 0.017 | -0.001 | 0.013 | 0.004 | 0.005 | -0.053 | 0.002 |
| Income Attributable to Non-Controlling Interest | 41.43 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -375.8 | -72.81 | -114.3 | -23.36 | -88.42 | -47.52 | -178.6 |
| Depreciation and Amortization | 4.04 | 4.05 | 4.15 | 4.45 | 3.78 | 3.78 | 3.75 |
| EBITDA | -259.3 | -79.35 | -101.3 | -46.18 | -32.06 | -31.48 | -134.9 |
| Earnings Per Share (EPS) | -33.08 | -19.43 | -44.85 | -6.09 | -23.29 | -0.013 | -1.27 |
| Diluted Earnings Per Share | -33.08 | -19.43 | -44.85 | -6.09 | -23.29 | -0.013 | -1.27 |
| Weighted Average Shares Outstanding | 11.6 | 6.95 | 3.72 | 3.83 | 3.8 | 4.03 | 4.03 |
| Diluted Weighted Average Shares Outstanding | 11.6 | 6.95 | 3.72 | 3.83 | 3.8 | 4.03 | 4.03 |
